A case examined by HealthNewsReview.org shows that even when a news release is hedged, the ensuing news stories can still be hyped. Kevin Lomangino compares a release and resulting article on resveratrol and Alzheimer’s: "Our reviewers praised the Georgetown University Medical Center release issued for the phase 2 safety study, calling it 'appropriately tempered and very informative' … but a Time magazine story about the study received low marks from our review team."
September 24, 2015
.png)
